|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Robotic rectal surgery: State of the art显示文摘Laparoscopic rectal surgery has demonstrated its superiority over the open approach, however it still has some technical limitations that lead to the development of robotic platforms. Nevertheless the literature on this topic is rapidly expanding there is still no consensus about benefits of robotic rectal cancer surgery over the laparoscopic one. For this reason a review of all the literature examining robotic surgery for rectal cancer was performed. Two reviewers independently conducted a search of electronic databases(Pub Med and EMBASE) using the key words 'rectum', 'rectal', 'cancer', 'laparoscopy', 'robot'. After the initial screen of 266 articles, 43 papers were selected for review. A total of 3013 patients were included in the review. The most commonly performed intervention was low anterior resection(1450 patients, 48.1%), followed by anterior resections(997 patients, 33%), ultra-low anterior resections(393 patients, 13%) and abdominoperineal resections(173 patients, 5.7%). Robotic rectal surgery seems to offer potential advantages especially in low anterior resections with lower conversions rates and better preservation of the autonomic function. Quality of mesorectum and status of and circumferential resection margins are similar to those obtained with conventional laparoscopy even if robotic rectal surgery is undoubtedly associated with longer operative times. This review demonstrated that robotic rectal surgery is both safe and feasible but there is no evidence of its superiority over laparoscopy in terms of postoperative, clinical outcomes and incidence of complications. In conclusion robotic rectal surgery seems to overcome some of technical limitations of conventional laparoscopic surgery especially for tumors requiring low and ultralow anterior resections but this technical improvement seems not to provide, until now, any significant clinical advantages to the patients. | Fabio Staderini Caterina Foppa Alessio Minuzzo Benedetta Badii Etleva Qirici Giacomo Trallori Beatrice Mallardi Gabriele Lami Giuseppe Macrì Andrea Bonanomi Siro Bagnoli Giuliano Perigli Fabio Cianchi | 2016 | World Journal of Gastrointestinal Oncology2016，8，11： | 7 |
| 2 | Adequacy of lymphadenectomy in laparoscopic colorectal cancer surgery : a single-centre, retrospective study 显示文摘 | Cianchi F Cortesini C Trallori G | 2012 | Surg Laparosc Endosc Percutan Tech2012，22，1： | 1 |
| 3 | Hodgkin’s Disease Risk Is Increased in Patients With Ulcerative Colitis显示文摘 | Domenico Palli* Giacomo Trallori? Siro Bagnoli? Calogero Saieva* Ottaviano Tarantino? Marco Ceroti* Giuseppe d’Albasio? Franco Pacini? Andrea Amorosi§ Giovanna Masala* | 2000 | Gastroenterology2000，，3： | 1 |
| 4 | Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis显示文摘 | Messori A Brignola C Trallori G | 1994 | Am J Gastroenterol1994，89，： | 1 |
| 5 | Adequacy of Lymphadenectomy in Laparoscopic Colorectal Cancer Surgery: A Single-centre, Retrospective Study显示文摘 | Fabio Cianchi Camillo Cortesini Giacomo Trallori Luca Messerini Luca Novelli Camilla Eva Comin Etleva Qirici Andrea Bonanomi Giuseppe Macrì Benedetta Badii Aurora Kokomani Giuliano Perigli | 2012 | Surgical Laparoscopy Endoscopy & Percutaneous Techniques2012，，1： | 1 |
| 6 | Defined-formula diets versus steroids in the treatment of active Crohn's disease:a meta-anal-ysis 显示文摘 | Messofi A Trallori G D'Albasio G | 1996 | Scand J Gastroenterol1996，31，3： | 1 |
| 7 | Adequacy of lymphadenectomy in laparoseopic colorectal cancer surgery:a single-centre, retrospective study显示文摘 | Cianchi F Cortesini C Trallori G | 2012 | Surgical Laparoscopy Endoscopy & Percutaneous Techniques2012，22，1： | 1 |
| 8 | Defined-formula diets versus steroids in the treatment of active Crohn's disease 显示文摘 | Trallori M D'Albasio G Milla M | 1996 | Scand J Gastroenterol1996，31，3： | 1 |
| 9 | A population-based study of inflammatory bowel disease in florence over 15 years (1978 -92 ) 显示文摘 | Trallori G Palli D Saieva C | 1996 | Scand J Gastroenterol1996，31，9： | 1 |
| 10 | Hodgkin’s Disease Risk Is Increased in Patients With Ulcerative Colitis显示文摘 | Domenico Palli* Giacomo Trallori? Siro Bagnoli? Calogero Saieva* Ottaviano Tarantino? Marco Ceroti* Giuseppe d’Albasio? Franco Pacini? Andrea Amorosi§ Giovanna Masala* | 2000 | Gastroenterology2000，，3： | 1 |
| 11 | Mesenchymal stem cells, implications for pain therapy显示文摘History and biology of mesenchymal stem cell (MSC): MSCs were firstly described around 1970s by Friedenstein and his collaborators as a subpopulation of colony forming, clonogenic, plastic adherent stromal bone marrow derived cells, with the capacity to regenerate other tissues (Murphy et al., 2013). Caplan (1991) proposed that these mesenchymal cells were “stem” because of their ability to differentiate to any lineage of mesodermal cells. The richest sources of MSCs are bone marrow and adipose tissue, but they can also be isolated from synovial fluid, periosteum, fetal organs, placenta, umbilical cord blood and amniotic fluid (Murphy et al., 2013;Sherman et al., 2015). | Elena Trallori Carla Ghelardini Lorenzo Di Cesare Mannelli | 2019 | Neural Regeneration Research2019，14，11： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员